My research focuses on using circulating tumor DNA (ctDNA) as a minimally invasive biomarker to detect molecular residual disease, monitor disease recurrence, and guide treatment decisions in colorectal cancer. A key part of my work is serial ctDNA analysis, which allows me to estimate tumor growth rates, which could be a promising tool for identifying particularly aggressive disease and guiding timely intervention.